JPMorgan Chase & Co’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-605,742
| Closed | -$12.9M | – | 6634 |
|
|
2024
Q1 | $12.9M | Buy |
605,742
+591,709
| +4,217% | +$12.6M | ﹤0.01% | 1967 |
|
|
2023
Q4 | $135K | Buy |
14,033
+14,031
| +701,550% | +$135K | ﹤0.01% | 4643 |
|
|
2023
Q3 | $5 | Hold |
2
| – | – | ﹤0.01% | 6404 |
|
|
2023
Q2 | $9 | Hold |
2
| – | – | ﹤0.01% | 5914 |
|
|
2023
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 6200 |
|
|
2022
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 6042 |
|
|
2022
Q3 | $0 | Sell |
2
-4,350
| -100% | – | ﹤0.01% | 5914 |
|
|
2022
Q2 | $11K | Hold |
4,352
| – | – | ﹤0.01% | 5167 |
|
|
2022
Q1 | $34K | Hold |
4,352
| – | – | ﹤0.01% | 5138 |
|
|
2021
Q4 | $18K | Buy |
4,352
+1,361
| +46% | +$5.63K | ﹤0.01% | 5353 |
|
|
2021
Q3 | $24K | Buy |
2,991
+948
| +46% | +$7.61K | ﹤0.01% | 5107 |
|
|
2021
Q2 | $17K | Buy |
2,043
+2,019
| +8,413% | +$16.8K | ﹤0.01% | 5144 |
|
|
2021
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 5427 |
|
|
2020
Q4 | $0 | Buy |
+24
| New | – | ﹤0.01% | 5152 |
|